Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency Journal Article


Authors: Motzer, R. J.; Niedzwiecki, D.; Isaacs, M.; Menendez-Botet, C.; Tong, W. P.; Flombaum, C.; Scher, H. I.; Bosl, G. J.
Article Title: Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency
Abstract: Three patients with renal insufficiency requiring hemodialysis were treated with carboplatin at 100 mg/m2 in combination with etoposide for advanced germ-cell tumor (GCT, two cases) or Adriamycin + vinblastine for a transitional-cell carcinoma of the ureter (one case). Hemodialysis was performed 24 h after the administration of carboplatin. Both patients with GCT achieved a complete response, and the patient with transitional-cell carcinoma of the ureter was inevaluable for response but his disease has not progressed. The dose of carboplatin was increased in one patient as renal function improved on therapy. In two patients, the pharmacokinetics of carboplatin were determined; the pre-dialysis half-lives, AUC, and total body clearances of free carboplatin-derived platinum were estimated to be 32 and 18.3 h, 4.93 and 6.17 mg ml-1 min, and 18.2 and 18.7 ml/min, respectively. The dialysis elimination half-lives (t1/2β) of 2 and 3 h, respectively, for these two patients were markedly lower than the predialysis values, indicating that carboplatin was dialyzed. In summary, carboplatin can be given to patients with severe renal insufficiency. Adequate AUCs were achieved and dialysis limited systemic exposure to free carboplatin. © 1990 Springer-Verlag.
Keywords: adult; case report; doxorubicin; carboplatin; etoposide; antineoplastic combined chemotherapy protocols; kidney failure; vinblastine; drug clearance; ureteral neoplasms; neoplasms, germ cell and embryonal; drug half life; carcinoma, transitional cell; germ cell tumor; hemodialysis; intravenous drug administration; kidney failure, chronic; renal dialysis; human; male; priority journal; article; support, non-u.s. gov't
Journal Title: Cancer Chemotherapy and Pharmacology
Volume: 27
Issue: 3
ISSN: 0344-5704
Publisher: Springer  
Date Published: 1990-05-01
Start Page: 234
End Page: 238
Language: English
DOI: 10.1007/bf00685719
PUBMED: 2176133
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 27 January 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Ping-Yiu Tong
    158 Tong
  2. Robert Motzer
    1243 Motzer
  3. Howard Scher
    1130 Scher
  4. George Bosl
    430 Bosl
  5. Marian Isaacs
    7 Isaacs